Mario Amendola
Mario Amendola
Genethon
Verified email at genethon.fr
Title
Cited by
Cited by
Year
Easy quantitative assessment of genome editing by sequence trace decomposition
EK Brinkman, T Chen, M Amendola, B van Steensel
Nucleic acids research 42 (22), e168-e168, 2014
9582014
Endogenous microRNA can be broadly exploited to regulate transgene expression according to tissue, lineage and differentiation state
BD Brown, B Gentner, A Cantore, S Colleoni, M Amendola, A Zingale, ...
Nature biotechnology 25 (12), 1457-1467, 2007
5732007
Single-cell dynamics of genome-nuclear lamina interactions
J Kind, L Pagie, H Ortabozkoyun, S Boyle, SS de Vries, H Janssen, ...
Cell 153 (1), 178-192, 2013
5052013
Forebrain ependymal cells are Notch-dependent and generate neuroblasts and astrocytes after stroke
M Carlén, K Meletis, C Göritz, V Darsalia, E Evergren, K Tanigaki, ...
Nature neuroscience 12 (3), 259, 2009
4572009
Stable knockdown of microRNA in vivo by lentiviral vectors
B Gentner, G Schira, A Giustacchini, M Amendola, BD Brown, M Ponzoni, ...
Nature methods 6 (1), 63-66, 2009
3402009
Coordinate dual-gene transgenesis by lentiviral vectors carrying synthetic bidirectional promoters
M Amendola, MA Venneri, A Biffi, E Vigna, L Naldini
Nature biotechnology 23 (1), 108-116, 2005
3242005
The cohesin release factor WAPL restricts chromatin loop extension
JHI Haarhuis, RH van der Weide, VA Blomen, JO Yáńez-Cuna, ...
Cell 169 (4), 693-707. e14, 2017
3022017
Genome-wide maps of nuclear lamina interactions in single human cells
J Kind, L Pagie, SS de Vries, L Nahidiazar, SS Dey, M Bienko, Y Zhan, ...
Cell 163 (1), 134-147, 2015
2852015
Generation of potent and stable human CD4+ T regulatory cells by activation-independent expression of FOXP3
SE Allan, AN Alstad, N Merindol, NK Crellin, M Amendola, R Bacchetta, ...
Molecular Therapy 16 (1), 194-202, 2008
2092008
Identification of hematopoietic stem cell–specific miRNAs enables gene therapy of globoid cell leukodystrophy
B Gentner, I Visigalli, H Hiramatsu, E Lechman, S Ungari, A Giustacchini, ...
Science translational medicine 2 (58), 58ra84-58ra84, 2010
1772010
Regulated and multiple miRNA and siRNA delivery into primary cells by a lentiviral platform
M Amendola, L Passerini, F Pucci, B Gentner, R Bacchetta, L Naldini
Molecular Therapy 17 (6), 1039-1052, 2009
992009
Mechanisms and dynamics of nuclear lamina–genome interactions
M Amendola, B van Steensel
Current opinion in cell biology 28, 61-68, 2014
982014
Induction of fetal hemoglobin synthesis by CRISPR/Cas9-mediated editing of the human β-globin locus
C Antoniani, V Meneghini, A Lattanzi, T Felix, O Romano, E Magrin, ...
Blood 131 (17), 1960-1973, 2018
782018
Nuclear lamins are not required for lamina‐associated domain organization in mouse embryonic stem cells
M Amendola, B van Steensel
EMBO reports 16 (5), 610-617, 2015
772015
Widespread enzymatic correction of CNS tissues by a single intracerebral injection of therapeutic lentiviral vector in leukodystrophy mouse models
A Lattanzi, M Neri, C Maderna, I di Girolamo, S Martino, A Orlacchio, ...
Human molecular genetics 19 (11), 2208-2227, 2010
672010
Efficient Tet-dependent expression of human factor IX in vivo by a new self-regulating lentiviral vector
E Vigna, M Amendola, F Benedicenti, AD Simmons, A Follenzi, L Naldini
Molecular therapy 11 (5), 763-775, 2005
662005
Oxidative stress and cell death in cells expressing L-ferritin variants causing neuroferritinopathy
A Cozzi, E Rovelli, G Frizzale, A Campanella, M Amendola, P Arosio, ...
Neurobiology of disease 37 (1), 77-85, 2010
652010
Reprogramming T lymphocytes for melanoma adoptive immunotherapy by T-cell receptor gene transfer with lentiviral vectors
S Bobisse, M Rondina, A Merlo, V Tisato, S Mandruzzato, M Amendola, ...
Cancer research 69 (24), 9385-9394, 2009
592009
Forkhead box protein 3 (FOXP3) mutations lead to increased TH17 cell numbers and regulatory T-cell instability
L Passerini, S Olek, S Di Nunzio, F Barzaghi, S Hambleton, M Abinun, ...
Journal of allergy and clinical immunology 128 (6), 1376-1379. e1, 2011
482011
Optimization of CRISPR/Cas9 delivery to human hematopoietic stem and progenitor cells for therapeutic genomic rearrangements
A Lattanzi, V Meneghini, G Pavani, F Amor, S Ramadier, T Felix, ...
Molecular Therapy 27 (1), 137-150, 2019
282019
The system can't perform the operation now. Try again later.
Articles 1–20